Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.125
Bid: 6.75
Ask: 7.50
Change: 0.00 (0.00%)
Spread: 0.75 (11.111%)
Open: 7.125
High: 7.125
Low: 7.125
Prev. Close: 7.125
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

20 Jun 2024 17:45

RNS Number : 2923T
IXICO plc
20 June 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BFXR4C20

Issuer Name

IXICO PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Amati Global Investors Limited

City of registered office (if applicable)

Edinburgh

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

Amati AIM VCT plc

London

United Kingdom

5. Date on which the threshold was crossed or reached

19-Jun-2024

6. Date on which Issuer notified

20-Jun-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

9.83

0.000000

9.83

4756300

Position of previous notification (if applicable)

10.75

0.000000

10.75

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BFXR4C20

4756300

9.83

Sub Total 8.A

4756300

9.83%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Correction of a previous notification.

12. Date of Completion

20-Jun-2024

13. Place Of Completion

Edinburgh, UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFMMFTMTITBBI
Date   Source Headline
29th Jun 20157:00 amRNSVirtualScopics Alliance Update
25th Jun 20151:21 pmRNSHolding(s) in Company
26th May 20157:01 amRNSRelease of beta version of MyBrainBook®
12th May 20157:00 amRNSLaunch of UK Government funded project
30th Apr 20157:49 amRNSLaunch of dementia care digital platform
24th Apr 20157:00 amRNSNew contract in Huntington's disease
11th Mar 20157:00 amRNSVirtualScopics, IXICO and Micron in collaboration
6th Mar 201511:38 amRNSResult of AGM
10th Feb 20154:25 pmRNSReplacement - Financial Results
10th Feb 20157:00 amRNSResults for the 16 month period ended 30 Sept 2014
16th Jan 20157:00 amRNSIXICO selected as EPAD imaging analysis partner
16th Dec 20147:00 amRNSLicense of TrialTracker to VirtualScopics
26th Nov 20147:00 amRNSAnnouncement of enhanced contracts
29th Oct 20147:30 amRNSGrant of Awards to Directors
17th Sep 20147:00 amRNSAppointment of Chief Financial Officer
7th Aug 20147:00 amRNSAdditional Listing
31st Jul 20144:19 pmRNSHolding(s) in Company
21st Jul 20144:33 pmRNSDirector/PDMR Shareholding
18th Jul 20147:00 amRNSTrading Update
19th Jun 20147:00 amRNSCollaboration with the MRC for dementia research
6th Jun 20147:00 amRNSHalf Yearly Report
22nd May 20147:00 amRNSTwo contracts in Huntington's disease awarded
30th Apr 20142:58 pmRNSHolding(s) in Company
16th Apr 20147:00 amRNSIXICO plc announces SBRI Healthcare contract
20th Mar 201412:41 pmRNSResults of AGM
11th Mar 20142:43 pmRNSDirector/PDMR Shareholding
11th Mar 201410:04 amRNSHolding(s) in Company
7th Mar 20142:35 pmRNSInternational alliance with VirtualScopics
28th Feb 20147:00 amRNSPublication of annual report and business update
6th Feb 20147:00 amRNSAppointment of Joint Broker
13th Jan 20149:51 amRNSPresents at Dementia Challenge seminar in Beijing
2nd Jan 20145:08 pmRNSHolding(s) in Company
17th Dec 20137:00 amRNSBusiness and trading update
13th Dec 20137:00 amRNSTSB Grant to Develop Dementia Diagnosis Products
11th Dec 20137:00 amRNSDementia diagnosis tool launch and InHealth update
10th Dec 20137:00 amRNSAttending G8 Global CEO Initiative on Alzheimer's
2nd Dec 201310:03 amRNSIXICO signs MOU with Beijing UMP
18th Nov 20136:00 pmRNSDirector/PDMR Shareholding
1st Nov 20134:01 pmRNSDirector/PDMR Shareholding
31st Oct 201311:26 amRNSDirector/PDMR Shareholding
22nd Oct 201312:29 pmRNSHolding(s) in Company
21st Oct 20131:22 pmRNSDirector/PDMR Shareholding
17th Oct 20133:08 pmRNSHolding(s) in Company
15th Oct 20137:00 amRNSFirst Day of Dealings
14th Oct 201312:18 pmRNSResult of General Meeting
14th Oct 201311:08 amRNSSchedule 1 update - Phytopharm Plc
11th Oct 20131:48 pmRNSSch 1 Update - Phytopharm plc
3rd Oct 20139:23 amRNSHolding(s) in Company
1st Oct 20137:00 amRNSDirector/PDMR Shareholding
30th Sep 20132:45 pmRNSSchedule 1 - Phytopharm Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.